Corey Babb
Gynecology · Tulsa, OKNPI 1427218593
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $134,400 of the $169,291 with a category attached, or 79.4%. Astellas Pharma US Inc accounts for 97.1% of it on its own, with 5 other manufacturers making up the rest.
Across 284 payments — averaging $596.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$164K
- AMAG Pharmaceuticals, Inc.$5K
- AbbVie$284
- Millicent US Inc$71
- Pfizer$27
- Bayer$17
What the payments were for
- Speaking & faculty fees$134,40079%
- Travel & lodging$27,88916%
- Food & beverage$6,5984%
- Education$4040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 260 | $164,370 |
| AMAG Pharmaceuticals, Inc. | 9 | $4,523 |
| AbbVie | 9 | $284 |
| Millicent US Inc | 4 | $71 |
| Pfizer | 1 | $27 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few gynecology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IntrarosaPrasterone (Dhea) | 25 | $7,554 |
| Estradiol | 16 | $698 |
| Estradiol (Twice Weekly)Estradiol | 24 | $540 |
| ProgesteroneProgesterone, Micronized | 18 | $465 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AMAG Pharmaceuticals, Inc.Intrarosa | $4,523 | $7,55425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in Oklahomaon file to place this against a meaningful peer group, so we don't.
Other gynecology in Tulsa
- Richard PolkTulsa$21
- Rebecca DeatonTulsa$16
- Kerri AnthonyOklahoma City$5K
- Deanna WrightTahlequah$1K
- Natalie JohnsonLawton$779
- Dennis SandlerOklahoma City$658
- Royice EverettOklahoma City$332
- Pablo PinzonOklahoma City$198
- Franklin BarnettMidwest City$104
- Michelle McElroyJenks$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.